Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial

Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain

(2013) Chiaki Miyazaki et al.   Clinical and Vaccine Immunology

IXIARO®updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis

(2013) Tomas Jelinek   Expert Review of Vaccines

A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines

(2012) E. O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine

(2012) Tabitha Woolpert et al.   VACCINE

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

(2012) Kenji Okada et al.   VACCINE

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

(2012) Akiko Kikukawa et al.   VACCINE

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

(2011) Elisabeth Schuller et al.   VACCINE

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea

(2011) Ratree Takhampunya et al.   Virology Journal

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

(2009) A. Kaltenböck et al.   VACCINE

Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

(2008) E. Tauber et al.   JOURNAL OF INFECTIOUS DISEASES